Clinical Trial Update: VentrAssistTM LVAD for the Treatment of Advanced Heart Failure - Destination Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial update for the VentrAssist LVAD as destination therapy in advanced heart failure; the snippet does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure

Drugs mentioned

• VentrAssist LVAD

Snippet

Sponsor: Ventracor | Conditions: End-stage Heart Failure, Cardiomyopathies | Phase 3 | Status: UNKNOWN